Chronic Kidney Disease (CKD)

Publishing Date : May, 2015
Report Code : HCMD107
Price:
Single license $3,600
Site license $5,400
Global license $7,200


Chronic Kidney Disease (CKD) Pipeline Analysis  gives comprehensive insight on the various drugs being developed for the treatment of CKD. The report covers all the drugs being developed in various phases (Discovery, Preclinical, Clinical & Marketing). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies and RNA-based therapeutics, but excludes symptom relief drugs. The report also covers some of the hot targets in research for CKD treatments.

This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the CKD Drug market. The report also provide strategic insights on medicines that are likely to have an impact on CKD treatment space and potentially alter standards of care in CKD in the foreseeable future.

  • 1     REPORT DESCRIPTION
  • 2     INTRODUCTION
    • 2.1     Causes & Symptoms
    • 2.2     Diagnosis
    • 2.3     Classification
    • 2.4     Epidemiology
  • 3     HOT TARGETS, MECHANISMS & THERAPIES
    • 3.1     Associated targets
    • 3.2     DNA vaccination
    • 3.3     Gene therapy
    • 3.4     Tissue engineering
  • 4     MARKET DATA
    • 4.1     Forecasting model
    • 4.2     Market dynamics
    • 4.3     Market sizing
    • 4.4     Cost burden
  • 5     PIPELINE ANALYSIS
    • 5.1     Development stage
    • 5.2     Modalities
    • 5.3     Leading players
    • 5.4     Innovative approaches
  • 6     SMALL MOLECULES
    • 6.1     Pipeline
    • 6.2     Competitive Analysis
  • 7     LARGE MOLECULE
    • 7.1     Pipeline
    • 7.2     Competitive Analysis
  • 8     MONOCLONAL ABs
    • 8.1     Pipeline
    • 8.2     Competitive Analysis
  • 9     STEMCELL THERAPY
    • 9.1     Pipeline
    • 9.2     Competitive Analysis
  • 10     RNA-BASED THERAPY
    • 10.1     Pipeline
    • 10.2     Competitive Analysis
  • 11     MAJOR PLAYERS
    • 11.1     Company Profiles
    • 11.2     Overview, Pipeline & Deals
  • 12     REFERENCES